TAKE Limited

TAKE Limited (TAKE) is a micro-cap Healthcare company valued at ₹187 crore operating in Healthcare Research, Analytics & Technology on the NSE and BSE.

Recent price move

TAKE Limited last traded at ₹12.02, modestly down 0.08% on the day.

Recent developments

On 2026-08-31, India's GDP growth in Q1 was 7.8%, defying expectations. Sectoral performance across agriculture, manufacturing, and services was surprisingly robust.

Financial performance

The company's annual net profit fell 70.7% to ₹11 crore, while revenue declined 34.1% year-on-year. The latest quarter showed a swing from a net loss of ₹1 crore to a profit of ₹1 crore, but revenue in the quarter was ₹30 crore, down from ₹54 crore in the prior year's quarter.

Valuation multiples

The stock trades at 16.2 times earnings, a discount to the Healthcare median of 32.0, 8.07 times book value.

Things to watch

The company's net profit margin jumped 7768.9 percentage points to 20.0%, but this follows a prior year margin of -7,748.9%. The company's revenue has declined 34.1% annually over the last three years and 41.2% over five years.

Where it stands

The company's latest quarter showed a swing from a net loss to a profit, but revenue and net profit have declined significantly over the past few years. The stock is 74.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.